Hartlepool cancer specialist hopes to '˜leave a legacy for the next generation'

A Hartlepool cancer specialist is set to spearhead new research which will '˜leave a legacy for the next generation'.

Thursday, 19th May 2016, 11:01 pm
Updated Friday, 20th May 2016, 8:21 am
UGC Mr Neil Richmond (from Hartlepool) the new Consultant Clinical Scientist at the Northern Centre for Cancer Care in Newcastle with Lady Elsie

Neil Richmond, 47, from Hartlepool, has been appointed to a new patient treatment and research role at the Northern Centre for Cancer Care (NCCC), Newcastle, has been created thanks to funding from the Sir Bobby Robson Foundation.

He has been appointed Consultant Clinical Scientist at the NCCC, which treats cancer patients from across the North East and Cumbria.

Sir Bobby Robson

Sign up to our daily newsletter

The i newsletter cut through the noise

He is helping optimise radiotherapy treatment for patients, leading treatment planning development and using innovative new software purchased by the Newcastle upon Tyne NHS Foundation Trust.

This new role will also mean the Centre can join and lead clinical trials in radiotherapy research, meaning it continues to play its role in finding better treatments for cancer patients.

Mr Richmond works closely with the team operating the Stereotactic Radiotherapy Unit at the NCCC, which opened in 2014 thanks to a special collaboration between the Newcastle upon Tyne Hospitals NHS Foundation Trust and local hospital charities.

The Sir Bobby Robson Foundation was the majority charitable contributor and made its largest contribution to date, £850,000, to help fund the unit, which uses detailed scans and computerised 4D treatment planning to deliver radiation with tremendous accuracy.

Sir Bobby Robson

Mr Richmond said: “Stereotactic radiotherapy is the major development in radiotherapy at present. It will define future treatments, so what we’re doing now will leave a legacy for the next generation.

“Working with this technology and the first class medical team here is what first attracted me to this role.

“It gives me great personal and professional satisfaction seeing the difference stereotactic radiotherapy is making in patient care.”

Mr Richmond is part of the team helping maximise use of stereotactic ablative body therapy (SABR) for tumours within the body, and stereotactic radiosurgery (SRS) for treating tumours within the brain.

On behalf of the Sir Bobby Robson Foundation, Lady Elsie says: “We have a marvellous board of trustees and it’s their medical knowledge that steers us. Every penny spent, every decision taken is discussed at great length to ensure it’s the best use of the money raised for us. And funding this post was no different.

“We’re so pleased to welcome Mr Richmond on board. He has a wealth of expertise and we’re lucky to have him. We wish him very well in his new role.”

The Sir Bobby Robson Foundation is helping continue the work which began when Sir Bobby launched his charity in 2008 and is helping find more effective ways to detect and treat cancer.

The charity funds projects that directly benefit patients from across the North East and Cumbria, and which contribute significantly to international research into cancer.

It has raised over £9 million and is intrinsically linked, and is a fund within, the Newcastle upon Tyne Hospitals NHS Charity. The substantial support it receives from this local NHS charity means it can significantly limit administrative costs.